| |
| |
|
| Insider
Information: |
Touchon Pascal |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,910,652 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,318,350 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,910,652 |
|
|
| Total
Value |
$1,318,350 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Atara Biotherapeutics, Inc. |
ATRA |
|
2024-03-04 |
1,910,652 |
2019-06-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRA |
Atara Biotherapeutics, In... |
President and CEO |
• • – |
2024-03-04 |
4 |
S |
$0.72 |
$17,888 |
D/D |
(24,844) |
1,910,652 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
President and CEO |
• • – |
2024-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,280,000 |
1,935,496 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
President and CEO |
• • – |
2023-11-16 |
4 |
S |
$0.39 |
$7,939 |
D/D |
(20,409) |
655,496 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
President and CEO |
• • – |
2023-08-16 |
4 |
S |
$1.65 |
$50,835 |
D/D |
(30,766) |
675,905 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
President and CEO |
• • – |
2023-06-27 |
4 |
S |
$1.66 |
$23,723 |
D/D |
(14,291) |
706,671 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
President and CEO |
• • – |
2023-05-16 |
4 |
S |
$2.04 |
$60,633 |
D/D |
(29,766) |
720,962 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
President and CEO |
• • – |
2023-03-02 |
4 |
AS |
$3.63 |
$56,868 |
D/D |
(15,679) |
750,728 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
President and CEO |
• • – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
324,711 |
766,407 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
President and CEO |
• • – |
2022-11-16 |
4 |
AS |
$4.49 |
$70,004 |
D/D |
(15,591) |
441,696 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
President and CEO |
• • – |
2022-08-16 |
4 |
AS |
$5.04 |
$74,548 |
D/D |
(14,806) |
457,287 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
President and CEO |
• • – |
2022-06-27 |
4 |
AS |
$7.20 |
$102,384 |
D/D |
(14,220) |
472,093 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
President and CEO |
• • – |
2022-05-17 |
4 |
AS |
$5.32 |
$73,962 |
D/D |
(13,913) |
486,313 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
President and CEO |
• • – |
2022-03-01 |
4 |
AS |
$9.86 |
$87,009 |
D/D |
(8,828) |
500,226 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
President and CEO |
• • – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
180,565 |
509,054 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
President and CEO |
• • – |
2021-11-16 |
4 |
AS |
$17.12 |
$143,816 |
D/D |
(8,402) |
328,489 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
President and CEO |
• • – |
2021-08-17 |
4 |
AS |
$12.53 |
$103,051 |
D/D |
(8,223) |
336,891 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
President and CEO |
• • – |
2021-06-25 |
4 |
AS |
$16.32 |
$231,660 |
D/D |
(14,194) |
345,114 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
President and CEO |
• • – |
2021-05-18 |
4 |
AS |
$14.55 |
$120,954 |
D/D |
(8,313) |
359,308 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
President and CEO |
• • – |
2021-03-02 |
4 |
AS |
$16.74 |
$81,808 |
D/D |
(4,887) |
367,621 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
President and CEO |
• • – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
117,187 |
372,508 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
President and CEO |
• • – |
2020-11-17 |
4 |
AS |
$19.77 |
$93,254 |
D/D |
(4,716) |
255,321 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
President and CEO |
• • – |
2020-08-18 |
4 |
AS |
$12.09 |
$58,117 |
D/D |
(4,807) |
260,037 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
President and CEO |
• • – |
2020-06-25 |
4 |
AS |
$12.92 |
$156,784 |
D/D |
(12,135) |
264,844 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
President and CEO |
• • – |
2020-05-18 |
4 |
AS |
$11.22 |
$35,848 |
D/D |
(3,195) |
276,979 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
President and CEO |
• • – |
2020-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
280,174 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
